MedTrace Logo

A Research Study to Explore the Impact of GP Support Via Text Messages to Patients With Asthma and/or COPD

NCT06419400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6053

Last updated 2024-05-20

No results posted yet for this study

Summary

A 6-month randomised controlled trial to evaluate the impact of text message support on symptom control and inhaler adherence for patients with asthma and/or COPD

Conditions

Interventions

BEHAVIORAL

Supportive text messages

The intervention group will receive a series of supportive text messages over the 6 month trial period, varying in content and frequency.

Sponsors & Collaborators

  • Lindus Health

    collaborator INDUSTRY

  • Accurx

    lead INDUSTRY

Principal Investigators

  • Luke Twelves · Lindus Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-09-15
Completion
2023-11-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06419400 on ClinicalTrials.gov